(Q41817920)

12 October 2017

Nukacin ISK-1, a bacteriostatic lantibiotic (English)

1 reference

12 October 2017

Sikder M Asaduzzaman

1

1 reference

12 October 2017

Jun-ichi Nagao

2

1 reference

12 October 2017

Hiroshi Iida

3

1 reference

12 October 2017

Takeshi Zendo

4

1 reference

12 October 2017

Jiro Nakayama

5

1 reference

12 October 2017

Kenji Sonomoto

6

1 reference

12 October 2017

language of work or name

English

0 references

publication date

8 June 2009

1 reference

Antimicrobial Agents and Chemotherapy

12 October 2017

1 reference

12 October 2017

53

1 reference

12 October 2017

8

1 reference

12 October 2017

3595-3598

1 reference

Nisin-induced changes in Bacillus morphology suggest a paradigm of antibiotic action.

12 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715603

The biology of lantibiotics from the lacticin 481 group is coming of age.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715603

Lysine-oriented charges trigger the membrane binding and activity of nukacin ISK-1.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715603

Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715603

Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715603

Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715603

Identification of rab12 as a secretory granule-associated small GTP-binding protein in atrial myocytes

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715603

The mode of action of SA-FF22, a lantibiotic isolated from Streptococcus pyogenes strain FF22.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715603

Mode of action of the lantibiotic mersacidin: inhibition of peptidoglycan biosynthesis via a novel mechanism?

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715603

An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715603

A novel type of immunity protein, NukH, for the lantibiotic nukacin ISK-1 produced by Staphylococcus warneri ISK-1.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715603

Lipid II is an intrinsic component of the pore induced by nisin in bacterial membranes

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715603

Purification and Partial Identification of Bacteriocin ISK-1, a New Lantibiotic Produced by Pediococcus sp. ISK-1

18 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19506061

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.01623-08

1 reference

12 October 2017

1 reference

12 October 2017

PubMed publication ID

19506061

1 reference